Skip to main content
Clinical Trials/ISRCTN22412590
ISRCTN22412590
Completed
Not Applicable

Pilot study for the treatment of heart failure with Pycnogenol

Kyoto University (Japan)0 sites30 target enrollmentDecember 6, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart failure
Sponsor
Kyoto University (Japan)
Enrollment
30
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 6, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kyoto University (Japan)

Eligibility Criteria

Inclusion Criteria

  • Patients over 40 years of age with chronic congestive heart failure (NYHA class II), known for at least 6 months which were previously untreated or treated with a diuretic and/or a low dose of an ACE inhibitor. Patients must have an exercise capacity of at least 75 watts as assessed by seated bicycle ergometry.

Exclusion Criteria

  • 1\. NYHA status I, III or IV
  • 2\. Treatment with digitalis within the previous 6 months
  • 3\. Exercise capacity of \>75 W for 2 min at the test during run\-in
  • 4\. Unstable angina or myocardial infarction within the last 6 months
  • 5\. Atrial fibrillation or ventricular arrhythmia greater than or equal to Lown III
  • 6\. Cardiac valvular disease or hypertrophic cardiomyopathy
  • 7\. Significant hypertension or hypotension (\< 60 mmHg or greater than or equal to 105 mmHg diastolic or \< 90 mmgH or \> 175 mmHg systolic)
  • 8\. Electrolyte disturbances, hyperuricemia, hypovolemia
  • 9\. Impaired renal function (creatinine \>1\.8 mg/dL) or hepatic function
  • 10\. Obstructive airways disease

Outcomes

Primary Outcomes

Not specified

Similar Trials